UBS Group’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-100
Closed -$1K – 8464
2015
Q1
$1K Sell
100
-33,700
-100% -$239K ﹤0.01% 8552
2014
Q4
$249K Buy
+33,800
New +$230K ﹤0.01% 4829

Other funds holding ARWR

UBS Group's ARWR Position: Q3 2026 in Review

UBS Group reduced its Arrowhead Research (ARWR) stake by 7.4% in Q3 2026, selling an estimated $5.18M and leaving 797,479 shares worth $52.2M. The position accounts for 0.01% of the portfolio, ranked #1659.

UBS Group first reported a position in ARWR in Q4 2014 and has held it in 48 quarters since. The position peaked at $83.8M in Q1 2026. 487 funds tracked by Wall St. Rank hold ARWR as of Q3 2026.

  • UBS Group held 797,479 shares of Arrowhead Research worth $52.2M as of Q3 2026.
  • UBS Group sold 64,041 Arrowhead Research shares in Q3 2026, an estimated $5.18M.
  • Arrowhead Research made up 0.01% of UBS Group's portfolio in Q3 2026, its #1659 holding.
  • UBS Group first reported a position in Arrowhead Research in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Arrowhead Research position peaked at $83.8M in Q1 2026.
  • 487 funds tracked by Wall St. Rank held Arrowhead Research as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.